Filing Flows › Albemarle (ALB) › Q3 2026 › vs Q3 2025
Albemarle (ALB) Q3 2026 vs Q3 2025 (year over year)
Albemarle's revenue rose $245M (+19%) from $1.3B in Q3 2025 to $1.6B in Q3 2026. Gross margin 19.4% against 9.0% (+10.4 pts).
Albemarle, Q3 2026: revenue $1.6B (+19% year over year), operating margin 9.5%, net earnings $297M, operating cash flow $406M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 19.4% | 9.0% | +10.4 pts |
| Operating margin | 9.5% | -16.6% | +26.1 pts |
| Net margin | 19.1% | -12.3% | +31.4 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.6B | $1.3B | $245M | +19% |
| Gross profit | $301M | $118M | $183M | +156% |
| Cost of revenue | $1.3B | $1.2B | $62.2M | +5% |
| Other income, net | $190M | $38.5M | $152M | +395% |
| Operating profit | $148M | −$217M | $365M | — |
| Operating expenses | $153M | $335M | −$182M | -54% |
| Pre-tax earnings | $339M | −$179M | $517M | — |
| Research & development | $8.2M | $12.7M | −$4.5M | -36% |
| SG&A | $136M | $139M | −$2.2M | -2% |
| Other operating costs | $8.0M | $183M | −$175M | -96% |
| Net earnings | $297M | −$161M | $457M | — |
| Minority interests | $19.9M | $12.8M | $7.2M | +56% |
| Income tax | $21.9M | −$30.6M | $52.5M | — |
| Depreciation & amortization | $168M | $164M | $3.9M | +2% |
| Share-based compensation | $9.6M | $11.0M | −$1.4M | -13% |
| Working capital & other | $68.9M | −$341M | $410M | — |
| Operating cash flow | $406M | $356M | $50.2M | +14% |
Questions
How much did Albemarle's revenue grow year over year in Q3 2026?
Albemarle's revenue rose $245M (+19%) from $1.3B in Q3 2025 to $1.6B in Q3 2026. Gross margin 19.4% against 9.0% (+10.4 pts).